港股異動 | 閲文集團(0772.HK)漲近6% 所參投的春節檔影視劇收穫觀眾良好口碑
格隆匯2月4日丨閲文集團(0772.HK)漲近6%,報40.65港元,總市值507億港元。由騰訊影業、新麗傳媒、閲文影視共同推出的現實題材大劇《人世間》已於1月28日在央視一套開播,首播收視率1.54,位列央衞電視劇黃金檔收視率第一、愛奇藝電視劇飆升榜第一,現列愛奇藝電視劇熱播榜第一。電影方面,新麗傳媒集團有限公司、天津閲文影視文化傳媒有限公司、西虹市影視文化(天津)有限公司、騰訊影業文化傳播有限公司等共同參與出品的《這個殺手不太冷靜》票房已突破7億元,位列春節檔票房第二。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.